Profile
Clive Morris worked as a Managing Director at CorpHQ, Inc. He was also an Investor Relations Contact at AstraZeneca PLC and President-Inivata at NeoGenomics, Inc. Morris was a Director at Inivata Ltd.
in 2022.
He holds a doctorate degree from The Royal College of Surgeons of England.
Former positions of Clive Morris
Companies | Position | End |
---|---|---|
Inivata Ltd.
Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Chief Executive Officer | 2021-06-17 |
NEOGENOMICS, INC. | Corporate Officer/Principal | 2022-06-29 |
CorpHQ, Inc. | Corporate Officer/Principal | 2007-08-05 |
ASTRAZENECA PLC | Public Communications Contact | - |
Training of Clive Morris
The Royal College of Surgeons of England | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
NEOGENOMICS, INC. | Health Services |
Private companies | 2 |
---|---|
CorpHQ, Inc. | Communications |
Inivata Ltd.
Inivata Ltd. Packaged SoftwareTechnology Services Inivata Ltd. develops new clinical applications for ctDNA analysis. It is a clinical cancer genomics company harnessing the potential of circulating tumour DNA (ctDNA) analysis to improve cancer testing and treatment. The firm is focused on developing clinical applications of ctDNA through collaborations with clinical oncologists at prominent academic institutions, leading community treatment centres and innovative biopharmaceutical companies. The company was founded by James Brenton, Tim Forshew, Rosenfeld Nitzan and Davina Gale on July 23, 2014 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
- Stock Market
- Insiders
- Clive Morris